ES2275343T3 - Aparato para inactivar contaminantes de un fluido biologico. - Google Patents
Aparato para inactivar contaminantes de un fluido biologico. Download PDFInfo
- Publication number
- ES2275343T3 ES2275343T3 ES99925587T ES99925587T ES2275343T3 ES 2275343 T3 ES2275343 T3 ES 2275343T3 ES 99925587 T ES99925587 T ES 99925587T ES 99925587 T ES99925587 T ES 99925587T ES 2275343 T3 ES2275343 T3 ES 2275343T3
- Authority
- ES
- Spain
- Prior art keywords
- light
- plasma
- biological fluid
- treatment
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000013060 biological fluid Substances 0.000 title claims abstract description 73
- 239000000356 contaminant Substances 0.000 title abstract description 15
- 230000000415 inactivating effect Effects 0.000 claims abstract description 5
- 239000011734 sodium Substances 0.000 claims description 33
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 32
- 229910052708 sodium Inorganic materials 0.000 claims description 32
- 239000012530 fluid Substances 0.000 claims description 28
- 239000000463 material Substances 0.000 claims description 23
- 239000002131 composite material Substances 0.000 claims description 4
- 239000003344 environmental pollutant Substances 0.000 claims description 4
- 231100000719 pollutant Toxicity 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 2
- 238000005289 physical deposition Methods 0.000 claims 1
- 238000001228 spectrum Methods 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 abstract description 44
- 238000000034 method Methods 0.000 abstract description 26
- 230000002779 inactivation Effects 0.000 abstract description 21
- 210000002381 plasma Anatomy 0.000 description 90
- 241000700605 Viruses Species 0.000 description 62
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 53
- 229960000907 methylthioninium chloride Drugs 0.000 description 52
- 210000004369 blood Anatomy 0.000 description 41
- 239000008280 blood Substances 0.000 description 40
- 230000003612 virological effect Effects 0.000 description 24
- 239000012503 blood component Substances 0.000 description 19
- 239000000306 component Substances 0.000 description 16
- 102000004169 proteins and genes Human genes 0.000 description 16
- 108090000623 proteins and genes Proteins 0.000 description 16
- 230000000694 effects Effects 0.000 description 15
- 238000011068 loading method Methods 0.000 description 14
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 13
- 238000010521 absorption reaction Methods 0.000 description 11
- 238000005286 illumination Methods 0.000 description 9
- 210000000265 leukocyte Anatomy 0.000 description 9
- 238000011084 recovery Methods 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 230000033001 locomotion Effects 0.000 description 8
- 108010049003 Fibrinogen Proteins 0.000 description 7
- 102000008946 Fibrinogen Human genes 0.000 description 7
- 108010094028 Prothrombin Proteins 0.000 description 7
- 238000003556 assay Methods 0.000 description 7
- 230000001413 cellular effect Effects 0.000 description 7
- 239000000645 desinfectant Substances 0.000 description 7
- 229920003023 plastic Polymers 0.000 description 7
- 239000004033 plastic Substances 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 230000006378 damage Effects 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 229940012952 fibrinogen Drugs 0.000 description 6
- 102000004506 Blood Proteins Human genes 0.000 description 5
- 108010017384 Blood Proteins Proteins 0.000 description 5
- 102100027378 Prothrombin Human genes 0.000 description 5
- 230000003834 intracellular effect Effects 0.000 description 5
- 229940039716 prothrombin Drugs 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 239000004698 Polyethylene Substances 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000002950 deficient Effects 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 239000010408 film Substances 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 108010047303 von Willebrand Factor Proteins 0.000 description 4
- 102100036537 von Willebrand factor Human genes 0.000 description 4
- 229960001134 von willebrand factor Drugs 0.000 description 4
- 108010054218 Factor VIII Proteins 0.000 description 3
- 102000001690 Factor VIII Human genes 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 238000001994 activation Methods 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 229960000301 factor viii Drugs 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000004023 fresh frozen plasma Substances 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 208000009305 pseudorabies Diseases 0.000 description 3
- WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 2
- MHIITNFQDPFSES-UHFFFAOYSA-N 25,26,27,28-tetrazahexacyclo[16.6.1.13,6.18,11.113,16.019,24]octacosa-1(25),2,4,6,8(27),9,11,13,15,17,19,21,23-tridecaene Chemical class N1C(C=C2C3=CC=CC=C3C(C=C3NC(=C4)C=C3)=N2)=CC=C1C=C1C=CC4=N1 MHIITNFQDPFSES-UHFFFAOYSA-N 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 108090000935 Antithrombin III Proteins 0.000 description 2
- 102000004411 Antithrombin III Human genes 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 102100022641 Coagulation factor IX Human genes 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- 108010076282 Factor IX Proteins 0.000 description 2
- 108010014173 Factor X Proteins 0.000 description 2
- 108010074864 Factor XI Proteins 0.000 description 2
- 241000725303 Human immunodeficiency virus Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 229960005348 antithrombin iii Drugs 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229960004222 factor ix Drugs 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 229950000688 phenothiazine Drugs 0.000 description 2
- 230000002186 photoactivation Effects 0.000 description 2
- -1 polyethylene Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229910052724 xenon Inorganic materials 0.000 description 2
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 2
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
- 229920002799 BoPET Polymers 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 102100023804 Coagulation factor VII Human genes 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- FBPFZTCFMRRESA-ZXXMMSQZSA-N D-iditol Chemical compound OC[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-ZXXMMSQZSA-N 0.000 description 1
- 108010014172 Factor V Proteins 0.000 description 1
- 108010023321 Factor VII Proteins 0.000 description 1
- 108010080865 Factor XII Proteins 0.000 description 1
- 102000000429 Factor XII Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 208000029462 Immunodeficiency disease Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 101150055771 MIRO1 gene Proteins 0.000 description 1
- 108010051456 Plasminogen Proteins 0.000 description 1
- 102000013566 Plasminogen Human genes 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 101800004937 Protein C Proteins 0.000 description 1
- 102000017975 Protein C Human genes 0.000 description 1
- 229940096437 Protein S Drugs 0.000 description 1
- 102000029301 Protein S Human genes 0.000 description 1
- 108010066124 Protein S Proteins 0.000 description 1
- 241001112090 Pseudovirus Species 0.000 description 1
- 101800001700 Saposin-D Proteins 0.000 description 1
- 102000005686 Serum Globulins Human genes 0.000 description 1
- 108010045362 Serum Globulins Proteins 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 241000701093 Suid alphaherpesvirus 1 Species 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 229920006397 acrylic thermoplastic Polymers 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000003114 blood coagulation factor Substances 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- BBFBNDYGZBKPIA-UHFFFAOYSA-K dichlorozinc [7-(diethylamino)phenothiazin-3-ylidene]-dimethylazanium chloride Chemical compound [Cl-].Cl[Zn]Cl.C1=CC(=[N+](C)C)C=C2SC3=CC(N(CC)CC)=CC=C3N=C21 BBFBNDYGZBKPIA-UHFFFAOYSA-K 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000008029 eradication Effects 0.000 description 1
- 229940012413 factor vii Drugs 0.000 description 1
- 229920002457 flexible plastic Polymers 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000007813 immunodeficiency Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- YYGBVRCTHASBKD-UHFFFAOYSA-M methylene green Chemical compound [Cl-].C1=CC(N(C)C)=C([N+]([O-])=O)C2=[S+]C3=CC(N(C)C)=CC=C3N=C21 YYGBVRCTHASBKD-UHFFFAOYSA-M 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 238000000678 plasma activation Methods 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229960000856 protein c Drugs 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000010517 secondary reaction Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 150000004992 toluidines Chemical class 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 238000001429 visible spectrum Methods 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
- A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Hydroponics (AREA)
- External Artificial Organs (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Professional, Industrial, Or Sporting Protective Garments (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81168 | 1998-05-18 | ||
| US09/081,168 US6190609B1 (en) | 1996-11-19 | 1998-05-18 | Methods and apparatus for inactivating contaminants in biological fluid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2275343T3 true ES2275343T3 (es) | 2007-06-01 |
Family
ID=22162516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES99925587T Expired - Lifetime ES2275343T3 (es) | 1998-05-18 | 1999-05-10 | Aparato para inactivar contaminantes de un fluido biologico. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6190609B1 (enExample) |
| EP (1) | EP1079868B1 (enExample) |
| JP (1) | JP2002515299A (enExample) |
| AT (1) | ATE342740T1 (enExample) |
| AU (1) | AU750131B2 (enExample) |
| CA (1) | CA2331404C (enExample) |
| DE (1) | DE69933669T2 (enExample) |
| DK (1) | DK1079868T3 (enExample) |
| ES (1) | ES2275343T3 (enExample) |
| NO (1) | NO321317B1 (enExample) |
| WO (1) | WO1999059645A1 (enExample) |
Families Citing this family (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7498156B2 (en) | 1998-07-21 | 2009-03-03 | Caridianbct Biotechnologies, Llc | Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components |
| US7049110B2 (en) | 1998-07-21 | 2006-05-23 | Gambro, Inc. | Inactivation of West Nile virus and malaria using photosensitizers |
| US6555054B1 (en) * | 1999-01-15 | 2003-04-29 | Steris Inc. | Flow through rack for contact point sterilization of rack supported medical devices |
| US7025877B1 (en) * | 1999-06-03 | 2006-04-11 | Baxter International Inc. | Processing set for processing and treating a biological fluid |
| US7445756B2 (en) * | 1999-06-03 | 2008-11-04 | Fenwal, Inc. | Fluid processing sets and organizers for the same |
| US7068361B2 (en) * | 1999-06-03 | 2006-06-27 | Baxter International | Apparatus, systems and methods for processing and treating a biological fluid with light |
| US6565802B1 (en) | 1999-06-03 | 2003-05-20 | Baxter International Inc. | Apparatus, systems and methods for processing and treating a biological fluid with light |
| US7220747B2 (en) | 1999-07-20 | 2007-05-22 | Gambro, Inc. | Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer |
| EP1214037B1 (en) * | 1999-09-16 | 2004-04-07 | Vasogen Ireland Limited | Apparatus for conditioning mammalian blood |
| US6843961B2 (en) | 2000-06-15 | 2005-01-18 | Gambro, Inc. | Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light |
| US6743190B2 (en) * | 2001-05-07 | 2004-06-01 | Biomed Solutions L.L.C. | Flow cytometer shunt |
| US7381976B2 (en) | 2001-03-13 | 2008-06-03 | Triton Thalassic Technologies, Inc. | Monochromatic fluid treatment systems |
| US20030030011A1 (en) * | 2001-05-17 | 2003-02-13 | Purepulse Technologies, Inc. | Light treatment control in a fluid treatment system using light for the treatment of fluid products |
| US20030060747A1 (en) * | 2001-05-17 | 2003-03-27 | Fries William M. | Fluid flow path for a fluid treatment system using light for the decontamination of fluid products |
| EP1693072A1 (en) * | 2002-04-26 | 2006-08-23 | Gambro, Inc., | Apparatus and method for irradiating and mixing fluids in containers |
| WO2003090795A1 (en) * | 2002-04-26 | 2003-11-06 | Gambro, Inc. | Apparatus and method for irradiating and mixing fluids in containers |
| US10966421B2 (en) | 2002-10-16 | 2021-04-06 | Streck, Inc. | Method and device for collecting and preserving cells for analysis |
| EP1687286A1 (en) * | 2003-11-28 | 2006-08-09 | Photopharmica Limited | Developments in biologically active methylene blue derivatives (2) |
| US8296071B2 (en) * | 2004-03-15 | 2012-10-23 | Terumo Bct Biotechnologies, Llc | Methods for uniformly treating biological samples with electromagnetic radiation |
| DE202004004263U1 (de) * | 2004-03-18 | 2004-05-19 | Weber, Waldfried | Bestrahlungsgerät für Blut |
| CN101031320A (zh) * | 2004-08-06 | 2007-09-05 | 约翰·肯尼迪 | 医疗设备和相关的附件、组成及治疗方法 |
| DE102004038592A1 (de) * | 2004-08-06 | 2006-03-16 | Ist Metz Gmbh | Bestrahlungsaggregat |
| US20060047281A1 (en) | 2004-09-01 | 2006-03-02 | Syneron Medical Ltd. | Method and system for invasive skin treatment |
| US20110015549A1 (en) * | 2005-01-13 | 2011-01-20 | Shimon Eckhouse | Method and apparatus for treating a diseased nail |
| US7400407B2 (en) * | 2005-08-31 | 2008-07-15 | Avago Technologies Ecbu Ip Pte Ltd | Meter for measuring the turbidity of fluids using reflected light |
| US9511344B2 (en) | 2007-12-18 | 2016-12-06 | Ultraviolet Sciences, Inc. | Ultraviolet light treatment chamber |
| US7511281B2 (en) * | 2005-08-31 | 2009-03-31 | Ultraviolet Sciences, Inc. | Ultraviolet light treatment chamber |
| US9808544B2 (en) * | 2005-08-31 | 2017-11-07 | Ultraviolet Sciences, Inc. | Ultraviolet light treatment chamber |
| CA113237S (en) | 2005-10-26 | 2009-07-15 | John Kennedy | Phototherapy device |
| CA2535276A1 (en) * | 2006-02-06 | 2007-08-06 | John Kennedy | Therapy device and system and method for reducing harmful exposure to electromagnetic radiation |
| KR101626167B1 (ko) * | 2008-01-17 | 2016-05-31 | 시네론 메디컬 리미티드 | 개인용 모발 제거 장치 및 그 사용 방법 |
| JP2011509791A (ja) * | 2008-01-24 | 2011-03-31 | シネロン メディカル リミテッド | 脂肪組織治療の機器、装置および方法 |
| WO2009149020A1 (en) * | 2008-06-04 | 2009-12-10 | Triton Thalassic Technologies, Inc. | Methods, systems and apparatus for monochromatic uv light sterilization |
| US9314293B2 (en) * | 2008-07-16 | 2016-04-19 | Syneron Medical Ltd | RF electrode for aesthetic and body shaping devices and method of using same |
| US20100017750A1 (en) * | 2008-07-16 | 2010-01-21 | Avner Rosenberg | User interface |
| US8778003B2 (en) * | 2008-09-21 | 2014-07-15 | Syneron Medical Ltd | Method and apparatus for personal skin treatment |
| WO2010078194A1 (en) | 2008-12-30 | 2010-07-08 | Streck, Inc. | Method for screening blood using a preservative that may be in a substantially solid state form |
| US11634747B2 (en) * | 2009-01-21 | 2023-04-25 | Streck Llc | Preservation of fetal nucleic acids in maternal plasma |
| DE202010018569U1 (de) * | 2009-02-18 | 2017-09-26 | Streck Inc. | Konservierung zellfreier Nukleinsäuren |
| US8606366B2 (en) | 2009-02-18 | 2013-12-10 | Syneron Medical Ltd. | Skin treatment apparatus for personal use and method for using same |
| CA2747767A1 (en) | 2009-02-25 | 2010-09-02 | Transpharma Medical Ltd. | Electrical skin rejuvenation |
| EP3103883A1 (en) * | 2009-11-09 | 2016-12-14 | Streck, Inc. | Stabilization of rna in and extracting from intact cells within a blood sample |
| CN102762154B (zh) | 2009-12-06 | 2015-12-02 | 赛诺龙医疗公司 | 用于个人皮肤护理的方法和设备 |
| US9956281B2 (en) | 2011-05-04 | 2018-05-01 | Streck, Inc. | Inactivated virus compositions and methods of preparing such compositions |
| JP6121409B2 (ja) | 2011-06-17 | 2017-04-26 | ロッシュ ダイアグノスティクス ヘマトロジー インコーポレイテッド | 生体試料の組織処理のための溶液 |
| WO2013023362A1 (zh) * | 2011-08-16 | 2013-02-21 | 深圳市卫武光明生物制品有限公司 | 静注巨细胞病毒人免疫球蛋白及其制备方法 |
| WO2015013244A1 (en) | 2013-07-24 | 2015-01-29 | Streck, Inc. | Compositions and methods for stabilizing circulating tumor cells |
| US11168351B2 (en) | 2015-03-05 | 2021-11-09 | Streck, Inc. | Stabilization of nucleic acids in urine |
| WO2016170511A1 (en) * | 2015-04-24 | 2016-10-27 | Limestone Labs Limited | Sanitizing device and method for sanitizing articles |
| US20170028121A1 (en) * | 2015-07-31 | 2017-02-02 | Fenwal, Inc. | Irradiation device for biological fluids |
| EP3355940A2 (en) | 2015-10-02 | 2018-08-08 | The U.S.A. as represented by the Secretary, Department of Health and Human Services | Inactivation of pathogens in ex vivo blood products in storage bags using visible light |
| US20170145475A1 (en) | 2015-11-20 | 2017-05-25 | Streck, Inc. | Single spin process for blood plasma separation and plasma composition including preservative |
| EP3491381B1 (en) | 2016-07-29 | 2025-09-24 | Streck LLC | Suspension composition for hematology analysis control |
| EP3422354B1 (en) * | 2017-06-29 | 2025-09-17 | Fenwal, Inc. | System and method for authenticating medical device disposable components |
| US20190099507A1 (en) * | 2017-09-29 | 2019-04-04 | Hyper Light Technologies, Llc | Hyper-wave sterilization cabinet |
| CA3079415A1 (en) | 2017-10-19 | 2019-04-25 | Streck, Inc. | Compositions for hemolysis and coagulation regulation and stabilization of extracellular vesicles |
| KR102867700B1 (ko) | 2017-12-29 | 2025-10-01 | 세루스 코포레이션 | 생물학적 유체를 처리하기 위한 시스템 및 방법 |
| BR112020019057A2 (pt) | 2018-03-21 | 2020-12-29 | Baxalta Incorporated | Método para obter uma composição, e, composição farmacêutica. |
| US12097383B2 (en) * | 2018-12-13 | 2024-09-24 | Fenwal, Inc. | Systems and methods for treating a biological fluid with light in the event of a bulb outage |
| US10642132B1 (en) * | 2019-04-02 | 2020-05-05 | Ortery Technologies, Inc. | Turntable and light box for ring photography |
| MX2021015653A (es) | 2019-06-22 | 2022-04-11 | Cerus Corp | Sistemas de tratamiento de fluidos biologicos. |
| US11883544B2 (en) | 2019-06-28 | 2024-01-30 | Cerus Corporation | System and methods for implementing a biological fluid treatment device |
| WO2021016077A1 (en) * | 2019-07-19 | 2021-01-28 | A. O. Smith Corporation | Uv led sterilizing tank |
| IT202000003407A1 (it) * | 2020-02-19 | 2021-08-19 | Pelham Crescent S R L | Macchina per la fotoferesi extracorporea di un fluido biologico |
| DE102020205036B4 (de) * | 2020-04-21 | 2022-08-11 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Vorrichtung und Verfahren zur Erzeugung eines Flüssigkeitsfilms eines flüssigen Mediums in einem Folienbeutel, sowie Anordnung zur kontrollierten Exposition eines flüssigen Mediums in einem Folienbeutel mit physikalischer Strahlung |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4546757A (en) * | 1982-07-16 | 1985-10-15 | Jakahi Douglas Y | Fixed position concentrating solar collector |
| US4608255A (en) | 1985-01-31 | 1986-08-26 | American National Red Cross | Biocompatible method for in situ production of functional platelets and product produced thereby lacking immunogenicity |
| JPS61275228A (ja) | 1985-03-14 | 1986-12-05 | バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテツド | 治療用タンパク組成物中のビ−ルスの光動的不活性化 |
| US4866282A (en) | 1986-08-26 | 1989-09-12 | Baxter International Inc. | Irradiation of blood products |
| US4952812A (en) | 1986-08-26 | 1990-08-28 | Baxter International Inc. | Irradiation of blood products |
| US4726949A (en) | 1986-08-26 | 1988-02-23 | Baxter Travenol Laboratories, Inc. | Irradiation of blood products |
| US4878891A (en) | 1987-06-25 | 1989-11-07 | Baylor Research Foundation | Method for eradicating infectious biological contaminants in body tissues |
| US5571666A (en) | 1988-10-28 | 1996-11-05 | Oklahoma Medical Research Foundation | Thiazine dyes used to inactivate HIV in biological fluids |
| US4921473A (en) | 1989-02-02 | 1990-05-01 | Therakos, Inc. | Multicomponent fluid separation and irradiation system |
| DE3930510A1 (de) | 1989-09-13 | 1991-03-21 | Blutspendedienst Dt Rote Kreuz | Verfahren zur inaktivierung von viren in blut und blutprodukten |
| US5503721A (en) | 1991-07-18 | 1996-04-02 | Hri Research, Inc. | Method for photoactivation |
| US5184020A (en) | 1989-10-26 | 1993-02-02 | Hearst David P | Device and method for photoactivation |
| US5087636A (en) | 1990-02-20 | 1992-02-11 | University Of British Columbia | Method to destroy malignant cells in mononuclear cell populations |
| US5545516A (en) | 1990-05-01 | 1996-08-13 | The American National Red Cross | Inactivation of extracellular enveloped viruses in blood and blood components by phenthiazin-5-ium dyes plus light |
| JP3051998B2 (ja) | 1990-12-20 | 2000-06-12 | バクスター、インターナショナル、インコーポレイテッド | 光活性療法及び細胞分離技術を用いる血液のような液体中の遊離の及び同伴された汚染物を同時に除去するためのシステム並びに方法 |
| WO1992011058A1 (en) | 1990-12-20 | 1992-07-09 | Baxter International Inc. | Systems and methods eradicating contaminants in fluids |
| ZA919934B (en) | 1990-12-20 | 1992-09-30 | Baxter Int | Systems and methods for eradicating contaminants using photoactive materials in fluids like blood using discrete sources of radiation |
| AU646533B2 (en) | 1990-12-20 | 1994-02-24 | Baxter International Inc. | Systems for eradicating contaminants in fluids |
| DE9102709U1 (de) * | 1991-03-07 | 1991-05-23 | Blutspendedienst der Landesverbände des Deutschen Roten Kreuzes Niedersachsen, Oldenburg und Bremen Gemeinnützige GmbH, 3257 Springe | Blutbeutelanordnung |
| US5269946A (en) | 1991-05-22 | 1993-12-14 | Baxter Healthcare Corporation | Systems and methods for removing undesired matter from blood cells |
| US5459030A (en) | 1992-03-02 | 1995-10-17 | Steritech, Inc. | Synthetic media compositions for inactivating bacteria and viruses in blood preparations with 8-methoxypsoralen |
| US5709991A (en) | 1992-03-02 | 1998-01-20 | Cerus Corporation | Proralen inactivation of microorganisms and psoralen removal |
| US5627426A (en) | 1993-03-22 | 1997-05-06 | General Electric Company | Lamp with IR reflecting film and light-scattering coating |
| US5593823A (en) | 1993-06-28 | 1997-01-14 | Cerus Corporation | Method for inactivating pathogens in blood using photoactivation of 4'-primary amino-substituted psoralens |
| US5427695A (en) | 1993-07-26 | 1995-06-27 | Baxter International Inc. | Systems and methods for on line collecting and resuspending cellular-rich blood products like platelet concentrate |
| US5691132A (en) | 1994-11-14 | 1997-11-25 | Cerus Corporation | Method for inactivating pathogens in red cell compositions using quinacrine mustard |
| US5527704A (en) | 1994-12-06 | 1996-06-18 | Baxter International Inc. | Apparatus and method for inactivating viral contaminants in body fluids |
| US5557098A (en) | 1994-12-20 | 1996-09-17 | Baxter International Inc. | System to identify bags disinfected by irradiation which punches holes in a polarized portion of the bag to indicate processing thereof |
| US5637451A (en) | 1995-03-29 | 1997-06-10 | New York Blood Center, Inc. | Photodynamic treatment of red blood cells with phthalocyanines and red light at higher light fluence rates is protective of red blood cells |
| US5606169A (en) | 1995-09-25 | 1997-02-25 | Westvaco Corporation | Ultraviolet light sterilization retrofit for paperboard packaging filling machines |
| US5922278A (en) * | 1996-11-19 | 1999-07-13 | Baxter International Inc. | Method and apparatus for inactivating contaminants in biological fluid |
-
1998
- 1998-05-18 US US09/081,168 patent/US6190609B1/en not_active Expired - Lifetime
-
1999
- 1999-05-10 ES ES99925587T patent/ES2275343T3/es not_active Expired - Lifetime
- 1999-05-10 EP EP99925587A patent/EP1079868B1/en not_active Expired - Lifetime
- 1999-05-10 DE DE69933669T patent/DE69933669T2/de not_active Expired - Lifetime
- 1999-05-10 CA CA002331404A patent/CA2331404C/en not_active Expired - Lifetime
- 1999-05-10 WO PCT/US1999/010303 patent/WO1999059645A1/en not_active Ceased
- 1999-05-10 JP JP2000549308A patent/JP2002515299A/ja active Pending
- 1999-05-10 AU AU41838/99A patent/AU750131B2/en not_active Expired
- 1999-05-10 DK DK99925587T patent/DK1079868T3/da active
- 1999-05-10 AT AT99925587T patent/ATE342740T1/de active
-
2000
- 2000-11-16 NO NO20005800A patent/NO321317B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20005800L (no) | 2001-01-11 |
| DE69933669T2 (de) | 2007-04-05 |
| US6190609B1 (en) | 2001-02-20 |
| CA2331404A1 (en) | 1999-11-25 |
| CA2331404C (en) | 2008-11-18 |
| DE69933669D1 (de) | 2006-11-30 |
| EP1079868A4 (en) | 2003-03-19 |
| NO321317B1 (no) | 2006-04-24 |
| NO20005800D0 (no) | 2000-11-16 |
| EP1079868A1 (en) | 2001-03-07 |
| EP1079868B1 (en) | 2006-10-18 |
| ATE342740T1 (de) | 2006-11-15 |
| AU4183899A (en) | 1999-12-06 |
| WO1999059645A1 (en) | 1999-11-25 |
| AU750131B2 (en) | 2002-07-11 |
| DK1079868T3 (da) | 2007-02-19 |
| JP2002515299A (ja) | 2002-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2275343T3 (es) | Aparato para inactivar contaminantes de un fluido biologico. | |
| EP0885018B1 (en) | Method and apparatus for inactivating contaminants in biological fluid | |
| EP0368902B1 (en) | Method for eradicating infectious contaminants in tissues | |
| ES2327951T3 (es) | Sistema para determinar unb cantidad eficaz de energia para su suministro a fluidos en fototerapia. | |
| ES2270838T3 (es) | Aparatos, sistemas y metodos para procesar y tratar con luz un fluido biologico. | |
| ES2550638T3 (es) | Sistema de bolsa de sangre y proceso para la desactivación de patógenos en concentrados de plaquetas mediante el uso del sistema de bolsa de sangre | |
| CA2688586C (en) | Irradiation apparatus for inactivating pathogens and/or leukocytes in a biological fluid and process | |
| US5866074A (en) | Systems for quantifying the illumination characteristics of vessels such as blood processing containers with respect to light energy | |
| KR101093423B1 (ko) | 유체 프로세싱 세트 및 유체 프로세싱 세트용 오거나이저 | |
| HU215131B (hu) | Eljárás vírusok inaktiválására vérben és vérkészítményekben | |
| JPH01500597A (ja) | 血液製品の照射 | |
| US9044523B2 (en) | Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light | |
| WO1999016308A1 (en) | Solar and full spectrum blood irradiation device and method | |
| Horowitz et al. | Viral Inactivation of Blood Products: A General Overview |